Publicaciones en colaboración con investigadores/as de Hospital Universitario del Henares (18)

2026

  1. Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

    Therapeutic Advances in Gastroenterology, Vol. 19

  2. Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study

    Australasian Journal of Dermatology, Vol. 67, Núm. 1, pp. e40-e44

  3. Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review

    International Journal of Dermatology, Vol. 65, Núm. 2, pp. 281-288

2025

  1. Characteristics of Asthma Patients Admitted to the Intensive Care Unit of a Tertiary University Hospital in Madrid, Spain: A 5-Year Experience

    Journal of Investigational Allergology and Clinical Immunology, Vol. 35, Núm. 1, pp. 50-52

  2. Drug Addiction in Gay and Bisexual Men Living with HIV Engaged in Sexualized Drug Use: Recent Drug Use, Polydrug and Depressive Symptoms as Predictors

    AIDS and Behavior, Vol. 29, Núm. 7, pp. 2324-2335

  3. Randomized Trial of Twice-Weekly Versus Thrice-Weekly Hemodiafiltration for Initiation of Renal Replacement Therapy

    Kidney International Reports, Vol. 10, Núm. 12, pp. 4188-4198

  4. Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study

    Blood Cancer Journal

  5. Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)

    Cancers, Vol. 17, Núm. 22

  6. Real-world evaluation of the effectiveness and safety of dupilumab in bullous pemphigoid: an ambispective multicentre case series

    British Journal of Dermatology, Vol. 192, Núm. 3, pp. 501-509

  7. Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU

    Digestive and Liver Disease, Vol. 57, Núm. 2, pp. 566-573

2024

  1. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine, Vol. 127, pp. 126-133

  2. Executive summary on the optimization of the multidisciplinary and integrated approach to polymyalgia rheumatica and giant cell arteritis in Madrid region

    Revista Clinica Espanola, Vol. 224, Núm. 1, pp. 48-56

  3. Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study

    American Journal of Kidney Diseases, Vol. 84, Núm. 6, pp. 719-730.e1

2023

  1. COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers, Vol. 15, Núm. 5

2021

  1. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

2020

  1. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease

    Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024

2019

  1. Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort

    Frontiers in Genetics, Vol. 10, Núm. FEB

2017

  1. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520